FIXX.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Stock prediction for FIXX.US - Homology Medicines Inc

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

symbol	last	change	%chng	name	mcap	sector	wiki
FIXX				Homology Medicines Inc	0.003B	Healthcare

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
C	FIXX	0.00	0,-0.463,-5.000,0.840,-0.463	0.58,0.62,0.68,0.70,0.73,0.85,0.91,0.89,0.91,7.07,0.93	0.55-0.71		267,112,267	5.2	Jan 4-Sep 27	52.65%

stock prediction graph

prediction values

stock	low target	target	high target	to go	days	target date
FIXX	0.55	0.63	0.71	103.77%	267	Sep 27
FIXX	0.57	0.62	0.68	102.66%	177	Jun 29
FIXX	0.57	0.62	0.68	102.55%	167	Jun 19
FIXX	0.57	0.62	0.67	102.16%	157	Jun 9
FIXX	0.57	0.62	0.67	102.27%	147	May 30
FIXX	0.58	0.62	0.67	102.71%	137	May 20
FIXX	0.58	0.62	0.67	102.62%	127	May 10
FIXX	0.58	0.62	0.66	102.12%	117	Apr 30
FIXX	0.58	0.62	0.66	101.87%	107	Apr 20
FIXX	0.58	0.61	0.65	101.05%	97	Apr 10

``` ```